Retatrutide is a synthetic, long-acting peptide developed for research into metabolic signaling pathways. It is structurally engineered to act as a multi-receptor agonist, interacting with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors in experimental models.
In laboratory settings, retatrutide is studied for its ability to modulate energy balance, glucose regulation, and lipid metabolism pathways. Its tri-agonist design distinguishes it from single- or dual-receptor peptides, making it a compound of interest in advanced metabolic research.
For research purposes only. Not for human consumption.
|
Specification
|
Detail
|
|
Compound Name
|
Retatrutide
|
|
Peptide Type
|
Synthetic multi-receptor agonist peptide
|
|
Molecular Formula
|
C₂₂₁H₃₄₂N₄₆O₆₈
|
|
Molecular Weight
|
~4,814.5 g/mol
|
|
Amino Acid Length
|
39 amino acids
|
|
Peptide Sequence
|
Proprietary (available upon request where applicable)
|
|
Purity
|
≥99% (HPLC verified)
|
|
Form
|
Lyophilized powder
|
|
Quantity
|
10 mg per vial
|
|
Solubility
|
Soluble in sterile aqueous solutions (research handling)
|
|
Testing
|
HPLC / MS
|
|
COA
|
Available per batch
|
|
Storage
|
Store refrigerated (2–8°C) or frozen for long-term stability
|
